Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Successful use of thalidomide for refractory esophageal Crohn's disease.

Barkin JA, Schonfeld WB, Deshpande AR.

Am J Gastroenterol. 2013 May;108(5):855-7. doi: 10.1038/ajg.2013.49. No abstract available.

PMID:
23644969
2.

Thalidomide in refractory vulvar ulcerations associated with Crohn's disease.

Kolivras A, De Maubeuge J, André J, Song M.

Dermatology. 2003;206(4):381-3.

PMID:
12771492
3.

[Esophageal Crohn's disease].

Gil-Simón P, Barrio J, Saracíbar E, Pérez-Miranda M, Julián L, Antonio Gil Ruiz J, Caro-Patón A.

Gastroenterol Hepatol. 2008 Feb;31(2):108-9. Spanish. No abstract available.

PMID:
18279653
4.

Cricopharyngeal Crohn's disease.

Rowe PH, Taylor PR, Sladen GE, Owen WJ.

Postgrad Med J. 1987 Dec;63(746):1101-2.

5.

Inflammatory bowel disease.

Marchetti F, Martelossi S, Ventura A.

N Engl J Med. 2002 Dec 12;347(24):1982-4; author reply 1982-4. No abstract available.

PMID:
12479198
6.

Thalidomide and refractory Crohn's disease: what is in the future?

Ng SC.

J Clin Gastroenterol. 2014 Jul;48(6):476-7. doi: 10.1097/MCG.0000000000000136. No abstract available.

PMID:
24781387
7.

Thalidomide in oral Crohn's disease refractory to conventional medical treatment.

Odeka EB, Miller V.

J Pediatr Gastroenterol Nutr. 1997 Aug;25(2):250-1. No abstract available.

PMID:
9252926
8.

Thalidomide for Crohn's disease.

Fishman SJ, Feins NR, D'Amoto RJ, Folkman J.

Gastroenterology. 2000 Aug;119(2):596. No abstract available.

PMID:
10960273
9.

Crohn's disease of the oesophagus. A case report.

Freson M, Kottler RE, Wright JP.

S Afr Med J. 1984 Sep 15;66(11):417-8.

PMID:
6484767
10.

Editorial: is thalidomide a good option for patients with refractory Crohn's disease?

Rogler G.

Aliment Pharmacol Ther. 2015 Apr;41(8):785-6. doi: 10.1111/apt.13106. No abstract available.

PMID:
25781038
11.

Thalidomide for Crohn's disease: high dose, low dose, or "no doze" at all?

Katz JA.

Inflamm Bowel Dis. 2000 May;6(2):152-3. No abstract available.

PMID:
10833076
12.

Disappearance of Crohn's ulcers in the terminal ileum after thalidomide therapy.

Hershfield NB.

Can J Gastroenterol. 2004 Feb;18(2):101-4.

PMID:
14997219
13.
14.

Editorial: is thalidomide a good option for patients with refractory Crohn's disease? Authors' reply.

Gerich M, Yoon J, Vasiliauskas E.

Aliment Pharmacol Ther. 2015 Apr;41(8):786. doi: 10.1111/apt.13136. No abstract available.

PMID:
25781039
15.

Re: Disappearance of Crohn's ulcers in the terminal ileum after thalidomide therapy. Can J Gastroenterol 2004; 18(2): 101-104.

Cohen LB.

Can J Gastroenterol. 2004 Jun;18(6):419; author reply 419. No abstract available.

PMID:
15230268
16.

Crohn's disease of the esophagus.

Geboes K, Janssens J, Rutgeerts P, Vantrappen G.

J Clin Gastroenterol. 1986 Feb;8(1):31-7.

PMID:
3701011
17.

Long-term outcomes of thalidomide in refractory Crohn's disease.

Gerich ME, Yoon JL, Targan SR, Ippoliti AF, Vasiliauskas EA.

Aliment Pharmacol Ther. 2015 Mar;41(5):429-37. doi: 10.1111/apt.13057. Epub 2014 Dec 15.

PMID:
25511905
18.

Thalidomide for the treatment of recalcitrant oral Crohn's disease and orofacial granulomatosis.

Hegarty A, Hodgson T, Porter S.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003 May;95(5):576-85.

PMID:
12738949
19.

Dysphagia and esophageal ulceration in Crohn's disease.

Gelfand MD, Krone CL.

Gastroenterology. 1968 Oct;55(4):510-4. No abstract available.

PMID:
5698629
20.

Treatment of esophageal Crohn's disease by enteral feeding via percutaneous endoscopic gastrostomy.

Thomas TS, Berto E, Scribano ML, Middleton SJ, Hunter JO.

JPEN J Parenter Enteral Nutr. 2000 May-Jun;24(3):176-9.

PMID:
10850945
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk